Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Cash Flows

v3.24.1.1.u2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Apr. 30, 2024
Apr. 30, 2023
Cash flows from operating activities:    
Net income (loss) $ (27,636) $ (44,224)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Amortization of intangible assets 31,583 38,245
Share-based compensation 7,153 9,128
Depreciation 760 1,144
Non-cash interest expense 536 664
Non-cash property, equipment, software and lease impairment charges 0 4,819
Provision for credit loss expense (recovery) 41 70
(Gain) loss on sale of business 0 682
Provision for (benefit from) income taxes – non-cash (2,932) (4,934)
Fair value adjustment of warrants (0) (2,852)
Fair value adjustment of interest rate swaps (7,746) (270)
Change in assets and liabilities:    
Accounts receivable 74,826 73,624
Prepaid expenses and other current assets, including long-term (1,206) 297
Right-of-use assets 1,270 43
Accounts payable (1,107) (4,340)
Accrued expenses and other liabilities, including long-term (19,830) (16,367)
Lease liabilities (1,684) (156)
Deferred revenues (39,091) (34,109)
Net cash provided by (used in) operating activities 14,937 21,464
Cash flows from investing activities:    
Purchase of property and equipment (153) (1,636)
Internally developed software - capitalized costs (4,364) (2,683)
Sale of SumTotal, net of cash transferred 0 (5,137)
Net cash used in investing activities (4,517) (9,456)
Cash flows from financing activities:    
Shares repurchased for tax withholding upon vesting of restricted stock-based awards (82) (296)
Payments to acquire treasury stock 0 (7,155)
Net cash provided by (used in) financing activities (4,252) (1,907)
Effect of exchange rate changes on cash and cash equivalents (3,087) (557)
Net increase (decrease) in cash, cash equivalents and restricted cash 3,081 9,544
Cash, cash equivalents and restricted cash, beginning of period 146,523 177,556
Cash, cash equivalents and restricted cash, end of period 149,604 187,100
Supplemental disclosure of cash flow information:    
Cash and cash equivalents 142,020 178,049
Restricted cash 7,584 9,051
Cash, cash equivalents and restricted cash, end of period 149,604 187,100
Term Loan Facility [Member]    
Cash flows from financing activities:    
Principal payments on Term loans (1,601) 0
Accounts Receivable Facility [Member]    
Cash flows from financing activities:    
Proceeds from facility, net of borrowings $ (2,569) $ 5,544